Physician profile
Hyojin Kwon
NPI 1801183777
$1,067.29
in general payments reported to CMS, 2019-2025
16 companies · $583 in 2025
The $583 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $53.74 · 2024: $431 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,067.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $208.60 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $203.52 | 2023-2025 | Zepbound, Mounjaro, Jardiance |
| Exact Sciences Corporation | $133.21 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $85.74 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $67.36 | 2024-2025 | Breztri, Farxiga |
| Abbvie INC. | $58.46 | 2024-2025 | |
| Glaxosmithkline, LLC. | $48.94 | 2023-2025 | Arexvy, Shingrix, Flulaval Quadrivalent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.46 | 2024 | Jardiance |
| Astellas Pharma US INC | $48.41 | 2025 | Veozah |
| Amgen INC. | $32.14 | 2025 | Otezla, Repatha |
| Globus Medical, INC. | $28.57 | 2025 | Senza |
| Abbott Laboratories | $25.07 | 2025 | Freestyle Libre 3 |
| Eisai INC. | $22.89 | 2024 | |
| Dynavax Technologies Corporation | $21.02 | 2025 | Heplisav-B |
| Bayer Healthcare Pharmaceuticals INC. | $18.66 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $16.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hyojin Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.